Eli Lilly weight loss pill orforglipron clears trial, paving way for approval

August 26, 2025

•

1 min read

•

CNBC

Eli Lilly now has the clinical trial data required to start filing for approvals of the drug for chronic weight management with global regulators.

Eli Lilly on Tuesday said its daily weight loss pill helped patients with obesity and Type 2 diabetes shed weight in a late-stage trial, meeting the study's main goal and clearing the way for the company to file for approval of the drug globally. The... [5382 chars]

Read Original Article

Source: CNBC

Visit Source

Share this article

Twitter Facebook

Back to business news